[1]
|
Khorana, A.A., et al. (2006) Thromboembolism in Hospitalized Neutropenic Cancer Patients. Journal of Clinical Oncol-ogy, 24, 484-490. https://doi.org/10.1200/JCO.2005.03.8877
|
[2]
|
Korte, W. (2008) Cancer and Thrombosis: An Increasingly Important Association. Supportive Care in Cancer, 16, 223- 228. https://doi.org/10.1007/s00520-007-0376-y
|
[3]
|
Sørensen, H.T., Mellemkjaer, L., Olsen, J.H. and Baron, J.A. (2000) Prognosis of Cancers Associated with Venous Thromboembolism. The New England Journal of Medicine, 343, 1846-1850.
https://doi.org/10.1056/NEJM200012213432504
|
[4]
|
Glassman, D., Bateman, N.W., Lee, S., et al. (2022) Molec-ular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. Cancers (Basel), 14, 1496. https://doi.org/10.3390/cancers14061496
|
[5]
|
Strøm Kahr, H., Christiansen, O.B., Juul Riddersholm, S., et al. (2021) The Timing of Venous Thromboembolism in Ovarian Cancer Patients: A Nationwide Danish Cohort Study. Journal of Thrombosis and Haemostasis, 19, 992-1000.
https://doi.org/10.1111/jth.15235
|
[6]
|
Satoh, T., Oki, A., Uno, K., et al. (2007) High Incidence of Silent Venous Thromboembolism before Treatment in Ovarian Cancer. British Journal of Cancer, 97, 1053-1057. https://doi.org/10.1038/sj.bjc.6603989
|
[7]
|
张佳佳, 张易. 卵巢癌伴肺栓塞患者术前溶栓结合新辅助化疗的护理[J]. 上海护理, 2016, 16(6): 59-61.
|
[8]
|
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版) [J]. 中华普通外科杂志, 2017, 32(9): 807-812. https://doi.org/10.3760/cma.j.issn.1007-631X.2017.09.032
|
[9]
|
Lee, A.Y. and Levine, M.N. (2003) Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation, 107, I17-I21. https://doi.org/10.1161/01.CIR.0000078466.72504.AC
|
[10]
|
Dunbar, A., Bolton, K.L., Devlin, S.M., et al. (2021) Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid Tumors. Blood, 137, 2103-2113. https://doi.org/10.1182/blood.2020007488
|
[11]
|
Zhu, C., Xu, Z., Zhang, T., et al. (2021) Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma. Journal of Cancer, 12, 2295-2316. https://doi.org/10.7150/jca.53395
|
[12]
|
Ye, S., Yang, J., Cao, D., et al. (2015) Characteristic and Prog-nostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study. PLOS ONE, 10, e0121818.
https://doi.org/10.1371/journal.pone.0121818
|
[13]
|
Abu Saadeh, F., Norris, L., O’Toole, S., et al. (2013) Tumour Expresion of Tissue Factor and Tissue Factor Pathway Inhibitor in Ovarian Cancer-Relationship with Venous Throm-bosis Risk. Thrombosis Research, 132, 627-634.
https://doi.org/10.1016/j.thromres.2013.09.016
|
[14]
|
Anglesio, M.S., George, J., Kulbe, H., et al. (2011) IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer. Clinical Cancer Research, 17, 2538-2548.
https://doi.org/10.1158/1078-0432.CCR-10-3314
|
[15]
|
Gi, T., Yamashita, A., Aman, M., et al. (2021) Tissue Fac-tor Expression and Tumor-Infiltrating T Lymphocytes in Ovarian Carcinomas and Their Association with Venous Thromboembolism. Pathology International, 71, 261-266.
https://doi.org/10.1111/pin.13074
|
[16]
|
Matsuo, K., Hasegawa, K., Yoshino, K., et al. (2015) Venous Thrombo-embolism, Interleukin-6 and Survival Outcomes in Patients with Advanced Ovarian Clear Cell Carcinoma. European Journal of Cancer, 51, 1978-1988.
https://doi.org/10.1016/j.ejca.2015.07.012
|
[17]
|
Zhou, Q., Zhu, C., Shen, Z., et al. (2020) Incidence and Potential Predictors of Thromboembolic Events in Epithelial Ovarian Carcinoma Patients during Perioperative Period. European Journal of Surgical Oncology, 46, 855-861.
https://doi.org/10.1016/j.ejso.2020.01.026
|
[18]
|
Khorana, A.A., Kuderer, N.M., Culakova, E., et al. (2008) Devel-opment and Validation of a Predictive Model for Chemotherapy-Associated Thrombosis. Blood, 111, 4902-4907. https://doi.org/10.1182/blood-2007-10-116327
|
[19]
|
Carrier, M., Le Gal, G., Bates, S.M. anderson, D.R. and Wells, P.S. (2008) D-Dimer Testing Is Useful to Exclude Deep Vein Thrombosis in Elderly Outpatients. Journal of Thrombosis and Haemostasis, 6, 1072-1076.
https://doi.org/10.1111/j.1538-7836.2008.03007.x
|
[20]
|
Habu, Y., Mitsuhashi, A., Hanawa, S., et al. (2021) High Prevalence of Pulmonary Embolism Prior to Cancer Therapies in Patients with Ovarian and Endometrial Cancers Detect-ed by Contrast-Enhanced CT Using D-Dimer as an Index. Journal of Surgical Oncology, 124, 106-114. https://doi.org/10.1002/jso.26471
|
[21]
|
Swier, N. and Versteeg, H.H. (2017) Reciprocal Links between Venous Thromboembolism, Coagulation Factors and Ovarian Cancer Progression. Thrombosis Research, 150, 8-18. https://doi.org/10.1016/j.thromres.2016.12.002
|
[22]
|
Marinho, A., Fernandes, G., Carvalho, T., et al. (2008) Non-tuberculous Mycobacteria in Non-AIDS Patients. Revista Portuguesa de Pneumologia, 14, 323-337. https://doi.org/10.1016/S0873-2159(15)30241-5
|
[23]
|
Heit, J.A., Ashrani, A., Crusan, D.J., et al. (2017) Reasons for the Persistent Incidence of Venous Thromboembolism. Thrombosis and Haemostasis, 117, 390-400. https://doi.org/10.1160/TH16-07-0509
|
[24]
|
Kodama, J., Seki, N., Fukushima, C., et al. (2013) Elevated Preopera-tive Plasma D-Dimer Levels and the Incidence of Venous Thromboembolism in Japanese Females with Gynecological Cancer. Oncology Letters, 5, 299-304.
https://doi.org/10.3892/ol.2012.970
|
[25]
|
Liang, S., Tang, W., Ye, S., et al. (2020) Incidence and Risk Factors of Preoperative Venous Thromboembolism and Pulmonary Embolism in Patients with Ovarian Cancer. Thrombosis Re-search, 190, 129-134.
https://doi.org/10.1016/j.thromres.2020.02.019
|
[26]
|
Chokshi, S.K., Gaughan, J.P. and Krill, L. (2022) Incidence and Patient Characteristics of Venous Thromboembolism during Neoadjuvant Chemotherapy for Ovarian Cancer. Jour-nal of Thrombosis and Thrombolysis, 53, 202-207.
https://doi.org/10.1007/s11239-021-02511-6
|
[27]
|
Greco, P.S., Bazzi, A.A., McLean, K., et al. (2017) Incidence and Timing of Thromboembolic Events in Patients with Ovarian Cancer Undergoing Neoadjuvant Chemotherapy. Ob-stetrics & Gynecology, 129, 979-985.
https://doi.org/10.1097/AOG.0000000000001980
|
[28]
|
Magnus, N., Garnier, D. and Rak, J. (2010) Oncogenic Epidermal Growth Factor Receptor Up-Regulates Multiple Elements of the Tissue Factor Signaling Pathway in Human Glioma Cells. Blood, 116, 815-818.
https://doi.org/10.1182/blood-2009-10-250639
|
[29]
|
Falanga, A., Panova-Noeva, M. and Russo, L. (2009) Pro-coagulant Mechanisms in Tumour Cells. Best Practice & Research Clinical Haematology, 22, 49-60. https://doi.org/10.1016/j.beha.2008.12.009
|